Theophylline Tablet, Extended Release
Product Images NDC 62332-025

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 62332-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Theophylline Er mg300

Theophylline Extended-Release Tablets 300 mg, oral extended-release tablets, label from Alembic Pharmaceuticals Inc. The label indicates a package containing 30 tablets, prescription-only with storage instructions, barcode, and manufacturing details for Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals Inc. in the USA.*

FDA Label Image

Theophylline Er450mg

Theophylline Extended-Release Tablets 450 mg oral tablets in a 30-tablet package. The label indicates dispensing in a child-resistant container and storage at 20-25°C. Manufactured by Alembic Pharmaceuticals Inc., with details including the NDC 62332-026-30 and usage instructions noted as Rx only.*

FDA Label Image

Structure (Theophylline Structure)

Chemical structure of the active ingredient theophylline, showing its molecular configuration with nitrogen, oxygen, carbon, and hydrogen atoms in a xanthine derivative framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.